Glen Eagle Advisors’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-800
| Closed | -$552 | – | 1037 |
|
|
2020
Q4 | $552 | Sell |
800
-1,600
| -67% | -$1.1K | ﹤0.01% | 939 |
|
|
2020
Q3 | $5.4K | Hold |
2,400
| – | – | ﹤0.01% | 685 |
|
|
2020
Q2 | $8.59K | Sell |
2,400
-1,600
| -40% | -$5.73K | ﹤0.01% | 589 |
|
|
2020
Q1 | $15.2K | Buy |
4,000
+3,200
| +400% | +$12.2K | 0.01% | 449 |
|
|
2019
Q4 | $2.41K | Buy |
+800
| New | +$2.41K | ﹤0.01% | 768 |
|